Transplantation News

Research presented at the ASN Kidney Week showed that although Black patients were more likely to be referred for transplantation, they were less likely than white patients to advance to subsequent stages in the process.

Transplant is widely considered the preferred modality of renal replacement therapy for patients with irreversible kidney failure.

A study of U.S. kidney transplant recipients showed no significant changes in cancer incidence during a period of 3 decades, with rates of graft failure and mortality remaining high.

Angion Biomedica Corp. has signed a licensing agreement with Vifor Pharma for the commercialization of ANG-3777, a drug shown to treat delayed graft function and cardiac surgery-associated AKI, according to a press release.

A study of living kidney donors in Denmark found that while donation was associated with a greater risk for hypertension, it did not appear to increase the likelihood of donors developing cardiovascular disease.

A study of Medicare beneficiaries showed those who participated in the transplant process received more intensive end-of-life care than other patients with end-stage kidney disease.

Allograft survival rate is 96% after a process improvement project developed a more in-depth education program, according to a presentation at the American Nephrology Nurses Association National Symposium.

Researchers from Canada have identified a set of quality indicators that, they contend, could help improve the processes used by transplant centers in the evaluation of living kidney donors.

After disseminating five types of appeals through online advertisements, researchers found that although “substantial attention” was generated based on click-rate, this did not lead to a significant increase in organ donor registrations.

A study of patients hospitalized with COVID-19 across the United States showed little difference in outcomes between solid organ transplant recipients and the general population.